BRIEF-Metals Acquisition Limited Announces Inclusion In The S&P/ASX 300 Index-March 2024-www.financetom.com

BRIEF-Metals Acquisition Limited Announces Inclusion In The S&P/ASX 300 Index

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Metals Acquisition Limited Announces Inclusion In The S&P/ASX 300 Index

Sep 6, 2024 1:27 PM

Sept 6 (Reuters) - Metals Acquisition Ltd ( MTAL ):

* METALS ACQUISITION LIMITED ANNOUNCES INCLUSION IN THE

S&P/ASX

300 INDEX

Source text for Eikon:

Further company coverage:

Previous page： Boeing Receives Pegasus Airlines Order for 100 737-10 Jets Next page： --Thor Industries Keeps Quarterly Dividend at $0.50 a Share, Payable Jan. 17 to Shareholders of Record Jan. 6

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Boeing Receives Pegasus Airlines Order for 100 737-10 Jets

Dec 19, 2024

11:31 AM EST, 12/19/2024 (MT Newswires) -- Boeing ( BA ) has received a firm order for 100 737-10 aircraft from Pegasus Airlines, the companies said Thursday. The carrier's agreement with the plane maker includes an option for 100 additional jets, they said. With Pegasus' latest order, total orders for the 737 MAX variant have risen to more than 1,200...

--Thor Industries Keeps Quarterly Dividend at $0.50 a Share, Payable Jan. 17 to Shareholders of Record Jan. 6

Dec 19, 2024

11:34 AM EST, 12/19/2024 (MT Newswires) -- Price: 96.41, Change: -0.43, Percent Change: -0.44 ...

American Airlines settles race discrimination lawsuit by Black men removed from flight

Dec 19, 2024

Dec 19 (Reuters) - American Airlines ( AAL ) has agreed to settle a race discrimination lawsuit by three Black men who were temporarily removed from a flight at the insistence of white flight attendants, according to a court filing on Thursday. The terms of the agreement were not disclosed, but lawyers for the men said the settlement includes a...

Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits

Dec 19, 2024

On Thursday, Prothena Corporation plc ( PRTA ) released results from the Phase 2b PADOVA study of prasinezumab in early-stage Parkinson’s disease. Partner Roche Holdings AG (OTC:RHHBY) conducted the 586-subject study investigating prasinezumab in early-stage Parkinson’s disease patients who had been treated for a minimum of 18 months while on stable symptomatic treatment. Prasinezumab showed a potential clinical effect in...